The folate receptor (FR) is a tumor-associated antigen that can bind with folic acid (FA) and
its conjugates with high affinity and ingests the bound molecules inside the cell via the …

The folate receptor is a cell surface protein that has recently been identified as a tumor
marker, due to its differential overexpression in several malignancies. Current research …

Folate receptors (FR) are cellular markers highly expressed in various cancer cells. Here,
we report on the synthesis of a novel folate-containing lipoconjugate (FC) built of 1, 2-di-O …

Targeting of liposomes with phospholipid-anchored folate conjugates is an attractive
approach to deliver chemotherapeutic agents to folate receptor (FR) expressing tumors. The …

Folate receptors (FRs) have been identified as cellular surface markers for cancer and
leukemia. Liposomes containing lipophilic derivatives of folate have been shown to …

Folate appended sterically-stabilized liposomes (FA–SL) were investigated for tumor
targeting. Liposomes were prepared using HSPC, cholesterol and FA–polyethylene glycol …

Tumour cell-targeted liposomal delivery has the potential to enhance the therapeutic efficacy
and reduce the toxicity of anticancer agents. Folate receptor (FR) expression is frequently …

The folate receptor has been identified as a marker for ovarian carcinomas and is also up-
regulated in many other types of cancer. Folate-conjugation has been successfully applied …

Folate polyethylene glycol-cholesterol hemisuccinate (folate-PEG-CHEMS) is a novel folate
ligand firstly synthesized by our group and demonstrated good stability and potential …

Folate-polymer-coated liposomes were developed for targeted chemotherapy using
doxorubicin (DXR) as a model drug. Folate-poly (L-lysine)(F–PLL) conjugates with a folate …